Report cover image

Global Age-Related Macular Degeneration (AMD) Disease Market - Industry Trends and Forecast to 2029

Publisher Data Bridge Market Research
Published May 01, 2022
Length 240 Pages
SKU # DAABD17330358

Description

Global Age-Related Macular Degeneration (AMD) Disease Market - Industry Trends and Forecast to 2029

Global age-related macular degeneration (AMD) disease market is projected to register a CAGR of 8.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:
Global Age-Related Macular Degeneration (AMD) Disease Market, By Types (Dry AMD and Wet AMD), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others) and Distribution Channel (Direct Tender And Retail Sales) Industry Trends and Forecast to 2029


Some of the major factors contributing to the growth of the global age-related macular degeneration (AMD) disease market are:
• Growing geriatric population
• Growing prevalence of macular degeneration
Market Players

The key market players for global age-related macular degeneration (AMD) disease market are listed below:
• REGENXBIO Inc.
• Astellas Pharma
• Ionis Pharmaceutics
• Ocugen Inc.
• Bayer
• Novartis AG
• PIXIUM VISION
• johnson and johnson
• IVERIC bio
• MeiraGTx Limited
• Gensight Biologics
• Adverum Biotechnologies
• Graybug Vision
• Kodiak Sciences
• Genentech, Inc.

Table of Contents

240 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Age-related Macular Degeneration (Amd) Disease Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel
4.2 Porter's Five Forces Model
5 Regulatory Framework
6 Market Overview
6.1 Drivers
6.1.1 Rising Prevalence Of Age-related Macular Degeneration
6.1.2 Increasing Geriatric Population
6.1.3 Increase In Pipeline Products
6.1.4 Increase In Strategic Initiative By Key Players
6.2 Restraints
6.2.1 High Cost Of Treatment And Procedures
6.2.2 Lack Of Enough Qualified Professionals
6.3 Opportunities
6.3.1 Increasing Research And Development
6.3.2 Increase In Awareness And Treatment-seeking Rate Of Amd
6.3.3 Emerging Reimbursement Policies For The Treatment
6.3.4 Increasing Product Approval For Age-related Macular Degeneration (Amd)
6.4 Challenges
6.4.1 Limited Access To Treatment
6.4.2 Stringent Government Regulations For Products
7 Global Age-related Macular Degeneration (Amd) Disease Market, By Type
7.1 Overview
7.2 Dry Amd
7.3 Wet Amd
7.3.1 Medications
7.3.2 Anti-vegf Therapy
7.3.3 Gene Therapy
7.3.4 Surgery
8 Global Age- Related Macular Degeneration (Amd) Disease Market, By End User
8.1 Overview
8.2 Hospitals
8.3 Specialty Clinics
8.4 Ambulatory Surgical Centers
8.5 Home Healthcare
8.6 Others
9 Global Age-related Macular Degeneration (Amd) Disease Market, By Distribution Channel
9.1 Overview
9.2 Retail Sales
9.2.1 Hospital Pharmacies
9.2.2 Retail Pharmacies
9.2.3 Others
9.3 Direct Tender
10 Global Age-related Macular Degeneration (Amd) Disease Market, By Region
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Russia
10.3.5 Italy
10.3.6 Spain
10.3.7 Netherlands
10.3.8 Switzerland
10.3.9 Poland
10.3.10 Turkey
10.3.11 Austria
10.3.12 Hungary
10.3.13 Norway
10.3.14 Ireland
10.3.15 Lithuania
10.3.16 Rest Of Europe
10.4 Asia-pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Singapore
10.4.7 Thailand
10.4.8 Indonesia
10.4.9 Philippines
10.4.10 Malaysia
10.4.11 Vietnam
10.4.12 Rest Of Asia-pacific
10.5 South America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Peru
10.5.4 Rest Of South America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Uae
10.6.4 Israel
10.6.5 Egypt
10.6.6 Kuwait
10.6.7 Rest Of Middle East & Africa
11 Global Age-related Macular Degeneration (Amd) Disease Market: Company Landscape
11.1 Company Share Analysis: Global
11.2 Company Share Analysis: North America
11.3 Company Share Analysis: Europe
11.4 Company Share Analysis: Asia-pacific
12 Swot Analysis
13 Company Profile
13.1 Novartis Ag
13.1.1 Company Snapshot
13.1.2 Revenue Analysis
13.1.3 Company Share Analysis
13.1.4 Product Portfolio
13.1.5 Recent Development
13.1.5.1 Agreement
13.2 Genentech, Inc.
13.2.1 Company Snapshot
13.2.2 Company Share Analysis
13.2.3 Product Portfolio
13.2.4 Recent Development
13.3 Bayer Ag
13.3.1 Company Snapshot
13.3.2 Revenue Analysis
13.3.3 Company Share Analysis
13.3.4 Product Portfolio
13.3.5 Recent Development
13.4 Adverum Biotechnologies, Inc.
13.4.1 Company Snapshot
13.4.2 Revenue Analysis
13.4.3 Product Portfolio
13.4.4 Recent Development
13.5 Astellas Pharma Inc.
13.5.1 Company Snapshot
13.5.2 Revenue Analysis
13.5.3 Product Portfolio
13.5.4 Recent Development
13.6 Graybug Vision Inc.
13.6.1 Company Snapshot
13.6.2 Revenue Analysis
13.6.3 Product Portfolio
13.6.4 Recent Development
13.7 Gensight Biologics
13.7.1 Company Snapshot
13.7.2 Revenue Analysis
13.7.3 Product Portfolio
13.7.4 Recent Developments
13.7.4.1 Event
13.7.4.2 Award
13.8 Ionis Pharmaceuticals
13.8.1 Company Snapshot
13.8.2 Revenue Analysis
13.8.3 Product Portfolio
13.8.4 Recent Development
13.8.4.1 Event
13.9 Iveric Bio
13.9.1 Company Snapshot
13.9.2 Product Portfolio
13.9.3 Recent Development
13.10 Johnson &Johnson Services, Inc.
13.10.1 Company Snapshot
13.10.2 Revenue Analysis
13.10.3 Product Portfolio
13.10.4 Recent Development
13.10.4.1 Collaboration
13.11 Kodiak Sciences Inc.
13.11.1 Company Snapshot
13.11.2 Product Portfolio
13.11.3 Recent Development
13.12 Meiragtx Limited
13.12.1 Company Snapshot
13.12.2 Product Portfolio
13.12.3 Recent Developments
13.12.3.1 Events
13.12.3.2 Award
13.12.3.3 Collaboration
13.13 Ocugen Inc.
13.13.1 Company Snapshot
13.13.2 Product Portfolio
13.13.3 Recent Developments
13.13.3.1 Investment
13.13.3.2 Clinical Trial
13.14 Pixium Vision
13.14.1 Company Snapshot
13.14.2 Revenue Analysis
13.14.3 Product Portfolio
13.14.4 Recent Development
13.14.4.1 Award
13.15 Regenxbio Inc.
13.15.1 Company Snapshot
13.15.2 Product Portfolio
13.15.3 Recent Developments
13.15.3.1 Event
13.15.3.2 Collaboration
13.15.3.3 Certification
14 Questionnaire
15 Related Reports
List Of Figures
Figure 1 Global Age-related Macular Degeneration (Amd) Disease Market: Segmentation
Figure 2 Global Age-related Macular Degeneration (Amd) Disease Market: Data Triangulation
Figure 3 Global Age-related Macular Degeneration (Amd) Disease Market: Droc Analysis
Figure 4 Global Age-related Macular Degeneration (Amd) Disease Market: Global Vs Regional Market Analysis
Figure 5 Global Age-related Macular Degeneration (Amd) Disease Market: Company Research Analysis
Figure 6 Global Age-related Macular Degeneration (Amd) Disease Market: Multivariate Modelling
Figure 7 Global Age-related Macular Degeneration (Amd) Disease Market: Interview Demographics
Figure 8 Global Age-related Macular Degeneration (Amd) Disease Market: Dbmr Market Position Grid
Figure 9 Global Age-related Macular Degeneration (Amd) Disease Market: End User Coverage Grid
Figure 10 Global Age-related Macular Degeneration (Amd) Disease Market: Vendor Share Analysis
Figure 11 Global Age-related Macular Degeneration (Amd) Disease Market: Segmentation
Figure 12 North America Is Expected To Dominate And Europe Is Growing At The Fastest Pace In Global Age-related Macular Degeneration (Amd) Disease Market In The Forecast Period Of 2022 To 2029
Figure 13 Increase In The Prevalence Of Age-related Macular Degeneration (Amd) And Growing Geriatric Population Are Driving The Global Age-related Macular Degeneration (Amd) Disease Market In The Forecast Period Of 2022 To 2029
Figure 14 Dry Amd Segment Is Expected To Account For The Largest Share Of The Global Age-related Macular Degeneration (Amd) Disease Market In 2022 & 2029
Figure 15 Europe Is The Fastest-growing Market In Global Age-related Macular Degeneration (Amd) Disease Market In The Forecast Period Of 2022 To 2029
Figure 16 Drivers, Restraints, Opportunities, And Challenges Of Global Age-related Macular Degeneration (Amd) Disease Market
Figure 17 Global Age-related Macular Degeneration (Amd) Disease Market: By Type, 2021
Figure 18 Global Age-related Macular Degeneration (Amd) Disease Market: By Type, 2022-2029 (Usd Million)
Figure 19 Global Age-related Macular Degeneration (Amd) Disease Market: By Type, Cagr (2022-2029)
Figure 20 Global Age-related Macular Degeneration (Amd) Disease Market: By Type, Lifeline Curve
Figure 21 Global Age-related Macular Degeneration (Amd) Disease Market: By End User, 2021
Figure 22 Global Age-related Macular Degeneration (Amd) Disease Market: By End User, 2022-2029 (Usd Million)
Figure 23 Global Age-related Macular Degeneration (Amd) Disease Market: By End User, Cagr (2022-2029)
Figure 24 Global Age-related Macular Degeneration (Amd) Disease Market: By End User, Lifeline Curve
Figure 25 Global Age-related Macular Degeneration (Amd) Disease Market: By Distribution Channel, 2021
Figure 26 Global Age-related Macular Degeneration (Amd) Disease Market: By Distribution Channel, 2022-2029 (Usd Million)
Figure 27 Global Age-related Macular Degeneration (Amd) Disease Market: By Distribution Channel, Cagr (2022-2029)
Figure 28 Global Age-related Macular Degeneration (Amd) Disease Market: By Distribution Channel, Lifeline Curve
Figure 29 Global Age-related Macular Degeneration (Amd) Disease Market: Snapshot (2021)
Figure 30 Global Age-related Macular Degeneration (Amd) Disease Market: By Region (2021)
Figure 31 Global Age-related Macular Degeneration (Amd) Disease Market: By Region (2022 & 2029)
Figure 32 Global Age-related Macular Degeneration (Amd) Disease Market: By Region (2021 & 2029)
Figure 33 Global Age-related Macular Degeneration (Amd) Disease Market: By Type (2022 & 2029)
Figure 34 North America Age-related Macular Degeneration (Amd) Disease Market : Snapshot (2021)
Figure 35 North America Age-related Macular Degeneration (Amd) Disease Market : By Country (2021)
Figure 36 North America Age-related Macular Degeneration (Amd) Disease Market : By Country (2022 & 2029)
Figure 37 North America Age-related Macular Degeneration (Amd) Disease Market : By Country (2021 & 2029)
Figure 38 North America Age-related Macular Degeneration (Amd) Disease Market : By Type (2022-2029)
Figure 39 Europe Age-related Macular Degeneration (Amd) Disease Market: Snapshot (2021)
Figure 40 Europe Age-related Macular Degeneration (Amd) Disease Market: By Country (2021)
Figure 41 Europe Age-related Macular Degeneration (Amd) Disease Market: By Country (2022 & 2029)
Figure 42 Europe Age-related Macular Degeneration (Amd) Disease Market: By Country (2021 & 2029)
Figure 43 Europe Age-related Macular Degeneration (Amd) Disease Market: By Type (2022-2029)
Figure 44 Asia-pacific Age-related Macular Degeneration (Amd) Disease Market: Snapshot (2021)
Figure 45 Asia-pacific Age-related Macular Degeneration (Amd) Disease Market: By Country (2021)
Figure 46 Asia-pacific Age-related Macular Degeneration (Amd) Disease Market: By Country (2022 & 2029)
Figure 47 Asia-pacific Age-related Macular Degeneration (Amd) Disease Market: By Country (2021 & 2029)
Figure 48 Asia-pacific Age-related Macular Degeneration (Amd) Disease Market: By Type (2022-2029)
Figure 49 South America Age-related Macular Degeneration (Amd) Disease Market: Snapshot (2021)
Figure 50 South America Age-related Macular Degeneration (Amd) Disease Market: By Country (2021)
Figure 51 South America Age-related Macular Degeneration (Amd) Disease Market: By Country (2022 & 2029)
Figure 52 South America Age-related Macular Degeneration (Amd) Disease Market: By Country (2021 & 2029)
Figure 53 South America Age-related Macular Degeneration (Amd) Disease Market: By Type (2022-2029)
Figure 54 Middle East & Africa Age-related Macular Degeneration (Amd) Disease Market: Snapshot (2021)
Figure 55 Middle East & Africa Age-related Macular Degeneration (Amd) Disease Market: By Country (2021)
Figure 56 Middle East & Africa Age-related Macular Degeneration (Amd) Disease Market: By Country (2022 & 2029)
Figure 57 Middle East & Africa Age-related Macular Degeneration (Amd) Disease Market: By Country (2021 & 2029)
Figure 58 Middle East & Africa Age-related Macular Degeneration (Amd) Disease Market: By Type (2022-2029)
Figure 59 Global Age-related Macular Degeneration (Amd) Disease Market: Company Share 2021 (%)
Figure 60 North America Age-related Macular Degeneration (Amd) Disease Market: Company Share 2021 (%)
Figure 61 Europe Age-related Macular Degeneration (Amd) Disease Market: Company Share 2021 (%)
Figure 62 Asia-pacific Age-related Macular Degeneration (Amd) Disease Market: Company Share 2021 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us